Matthew Davidson

Matthew Davidson

Director/Board Member at ADIAL PHARMACEUTICALS, INC.

Net worth: 770 350 $ as of 30/06/2026

42 year
Health Technology
Consumer Services

Profile

Matthew Davidson was the founder of Verrica Pharmaceuticals, Inc., founded in 2013, where the title held was Chief Scientific Officer & Director.
Dr. Davidson is the founder of Azora Therapeutics, Inc., founded in 2019, holding the titles of President, Chief Executive & Financial Officer.
Dr. Davidson currently holds the position of Director & Chief Development Officer at Adial Pharmaceuticals, Inc., starting in 2026.
Dr. Davidson completed undergraduate education at the University of California, Berkeley, and earned a doctorate from Stanford University School of Medicine.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
12/06/2026 300,918 ( 13.75% ) 770 350 $ 30/06/2026

Matthew Davidson active positions

CompaniesPositionStart
ADIAL PHARMACEUTICALS, INC. Director/Board Member 11/06/2026
Chief Executive Officer 01/03/2019

Former positions of Matthew Davidson

Training of Matthew Davidson

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

14

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies5

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Matthew Davidson